Features including age, sex, performance status, number of metastasis organs, liver metastasis events, lymph node metastasis events, and initial HER2 status did not significantly influence survival (Fig. 2A). The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.